Enhanced Recovery Pathway Boosting Postsurgical Outcomes in Peritoneal Metastasis Patients
![](https://www.brighamhealthonamission.org/wp-content/uploads/2023/02/Melnitchouk-resized.jpg)
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to improve clinical outcomes and prognosis in patients with peritoneal metastasis. However, it is associated with a significant complication rate and a long postsurgical recovery in the hospital.
Read More